these are not the stocks you are looking for.........
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Why has this not gone up or even raised! Makes me nervous because how much i have! When will they release so PR
With the 8k released and the news and how well this company has done over the years. I honestly believe this could be a $3.00 stock by the end of the year! Very reputable company for many many years. Solid investment!
I guess i dont understand the year is almost half over why are the financials not filed?
When are we seeing news!
Yavich i was wondering the same thing lol
Allllllll talk! I bet you dont selll!
i bet the orders are sooo thin at 4s, 5s and 6s!!! man im ready for her to pop!!!
Couldnt pass up crack at the last of the 2s! grabbed just under 5mil more!!! GOOOOO LIGA!!! make me a proud owner?
I dont know w are awfully close to the 1s and the 2s are up. im debating on weather to grab more 2s or in hope pick up 1s. I understand people got to want to get out of liga to hand me those 1s!!! not sure what to do!! i know this is very thin and ready to pop! we are at the deciding point on people wanting the lowest before it blows up!! Ohhhhhhh the what to do!!!
I have contacted a couple companys in regards to updates and still no responses weeks later! Some companys just dont always have good feed back. One of the companys i am still waiting on is at .81 its not a scam its been going up slowly for a while but they never respond! Just a thought to keep in mind before you full all out bash a pinky! This one I feel is legit! with a shit load of potential!!
AHHH ok thanks! yeah for some reason I cant get level 2 to work on my mac!
lol ive had 10mil on 1s for a while hopeing someone would market drop or wed dip for me to pick up to a skyrocket out of this hole!! hahaha but im sitting heavy right now! so Im ready for the ride up!
Who is BMAK that everyone talks about!! lol
Feller thats because it has been filling my order all morning little by little as im sure with a couple other people.
+1 shareholders 0 MM lol LETS go LIGA!!!!
What kind of peak do think we will see CHUGIT?
Much agreed Chugit!! the more of us that hold the majority of the shares lower forces the ask price with faster!! as she climbs there will be less shares on the ask and will be slapin her butt to pennyland i hope!!
GO LIGA!!!
cant wait for the PR!!!! this stock is going to explode!!!
If youd like to hit market order for 9mil i can lighten your share count! :)
Awe lol you didnt fill my whole order!!! i still want your 2s if your soo gracious enough to sell them!!! We may never see 2s again. GOO LIGA!!!
Waiting on my replys from PR. SO far things are looking good and no dilution! Financials should be released here soon too!
Good news coming! get the low ones while you can
April 9, 2015
Acura Pharmaceuticals to Develop Abuse Deterrent Hydrocodone With Acetaminophen Tablets With Limitx(TM) Technology
Immediate-Release Tablets Intended to Address Excess Oral Consumption
PALATINE, IL -- (Marketwired) -- 04/09/15 --
Acura Pharmaceuticals Inc. (NASDAQ: ACUR), announced today that it is initiating development of an immediate-release hydrocodone bitartrate with acetaminophen tablet ("hydrocodone/APAP") incorporating Acura's novel LIMITX™ abuse deterrent technology. Hydrocodone/APAP, with over 135 million dispensed prescriptions in 2014 in the United States, is the largest prescribed opioid to treat moderate to severe pain. It also is the single most abused prescription opioid, predominately by swallowing multiple tablets. LIMITX is designed specifically to address this route of abuse.
The Food and Drug Administration's (FDA) April 2015 Abuse-Deterrent Opioids Evaluation and Labeling Guidance singles out immediate-release combination opioids with acetaminophen as being predominately abused by the oral route and that reducing nasal snorting of these products may not be meaningful. Development of the Company's LIMITX technology is currently being supported by a grant from the National Institute on Drug Abuse of the National Institutes of Health (NIH) to develop an immediate-release hydromorphone tablet. The Company intends to initiate formulation development of the LIMITX hydrocodone/APAP tablet upon the conclusion of formulation optimization of the LIMITX hydromorphone product. Acura had previously advanced the development of a hydrocodone/APAP product using our AVERSION® technology, which was designed to deter nasal snorting, but intends to indefinitely suspend those efforts.
"Based on the recent FDA Guidance as well as comments made by the former-FDA Commissioner at a March 2015 Appropriation Hearing, we believe the best course for Acura is to develop immediate-release acetaminophen combination opioids with our novel LIMITX technology", said Bob Jones, President and CEO of Acura. "We are pleased to be partnered with the NIH on our LIMITX technology and believe it may also be applicable to snorting abuse, which we continue to believe is a route of abuse for these products that needs addressing."
About Limitx™ Technology
LIMITX technology is an early stage technology separate and apart from the Company's other abuse deterrent technologies, Aversion® and Impede®. LIMITX is a novel formulation of common pharmaceutical ingredients intended to address abuse by excess oral consumption of multiple tablets. In proof of concept laboratory tests, LIMITX demonstrated the ability to limit the release of the active ingredient from tablets when multiple tablets are simultaneously introduced into simulated gastric fluid. Acura has patents pending with the U.S. Patent and Trademark office covering its LIMITX technology.
Phase I Research on the Company's hydromorphone tablet utilizing LIMITX technology is supported by the National Institute on Drug Abuse of the National Institutes of Health under Award Number R44DA037921. The results and content of any such research is solely the responsibility of Acura and does not necessarily represent the official views of the National Institutes of Health.
About Acura Pharmaceuticals
Acura Pharmaceuticals is a specialty pharmaceutical company engaged in the research, development and commercialization of product candidates intended to address medication abuse and misuse, utilizing its proprietary LIMITX™, AVERSION® and IMPEDE® Technologies. LIMITX contains ingredients that are intended to reduce or limit the rate or extent of opioid release when multiple tablets are ingested. AVERSION contains polymers that cause the drug to gel when dissolved; it also contains compounds that irritate the nasal passages if the product is snorted. IMPEDE is designed to disrupt the processing of pseudoephedrine from tablets into methamphetamine.
In June 2011, the U.S. Food and Drug Administration approved OXAYDO™ (oxycodone HCl immediate-release tablets) which incorporates the AVERSION Technology. On January 7, 2015, we entered into a Collaboration and License Agreement with Egalet US, Inc. and Egalet Ltd., each a subsidiary of Egalet Corporation, pursuant to which we exclusively licensed to Egalet worldwide rights to manufacture and commercialize OXAYDO.
Acura also markets NEXAFED® and NEXAFED® Sinus, which are pseudoephedrine containing products that utilize the IMPEDE technology.
Forward-Looking Statements
Certain statements in this press release constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Forwarding-looking statements may include, but are not limited to, the results of our clinical development of our hydrocodone/APAP product using our LIMITX technology, whether our hydrocodone/APAP formulation will lead to a commercial product, whether or when we are able to obtain FDA approval of this product candidate, whether we will be able to promote the abuse-deterrent features of our LIMITX technology, whether our product candidates utilizing our LIMITX technology will actually deter excess oral consumption or nasal snorting, and whether competitors will develop and commercialize products using alternative abuse-deterrent technologies that are more effective than our LIMITX technology. Such forwarding-looking statements involve known and unknown risks, uncertainties and other factors which may cause our actual results, performance or achievements to be materially different from any future results, performance, or achievements expressed or implied by such forward-looking statements. These statements reflect our current views with respect to future events and are based on assumptions and subject to risks and uncertainties. Given these uncertainties, you should not place undue reliance on these forward-looking statements. We discuss many of these risks in greater detail in our filings with the Securities and Exchange Commission. Unless required by law, we undertake no obligation to update or revise any forward-looking statements to reflect new information or future events or developments.
Contact:
Acura Investor Relations
Email contact
847-705-7709
Acura Media Relations
Email contact
Source: Acura Pharmaceuticals, Inc.
News Provided by Acquire Media
LIGA back at .0002 :( who killed the momentum!!! slap that ASK!!!
Go LIGA buy up those three's once that news hits! no moreand on the way to .0025!!!!
GO LIGA
more people buy at .0003!!!
lots of volume already today!
I would like to pick up another 40mil on monday at .0001!!!!
Come on LIGA!!!
When is the PR supposed to be released?
How is this not out on the breakout? Rise to the sky THCZ!!! SHOW ME THE MONEY!
What is the potential this could get to?
Thanks pugillista i will do that!
Holy Crap :( I was told about this at .015 and didnt jump on!! I hope i can get in at a decent price on monday!!! CRAP!!!!!
good deal looking for awesome PR!!! GO LIGA!!!
Is this your target price?
i just got on in this rocket ship!! ready for this to take off!!!!
and down she goes!!!!!!!!
We shall see!!!
GO MFST
.04 back in nov
I would like to honestly like to make my money back at this point. No new PR or strength like we all thought! If it Hits it Hits oh well.
GO MFST!!!
Waiting on that good PR!!